Ara-c/cytarabine is what?

Cytarabine. Cytarabine is in a class of medications called antimetabolites. It works by slowing or stopping the growth of cancer cells in your body.It is used in combination with other chemotherapy to treat acute leukemia. See more here: http://www.Nlm.Nih.Gov/medlineplus/druginfo/meds/a682222.Html.

Related Questions

What are side effects of chemo. W/ ara-c and daunamyacin?

Ara-C & daunorubicin. Combination of ara-c and Daunorubicin is used to treat acute leukemia. They may cause nasuea, vomiting, hair loss, weakness, supression to bone marrow, infection, diarrhea, headache, etc a detail discussion with your oncologist has to be done prior to administration of these drugs. See more here:http://www.Nlm.Nih.Gov/medlineplus/druginfo/meds/a682222.Html;. Read more...

Other then ara-c, what other drugs are currently used for leukemia?

There are >1 type of. I assume that your question is about Acute leukemia where Ara-C is commonly used. This is typically given in combination with other drugs like Daunorubicin or Idarubicin( for AML) and sometimes with Methotrexate(for ALL) Read more...

Aside from ara-c, what alternative drugs are currently used for leukemia?

Anti-Leukemic Drugs. Anthracyclines like Daunorubicin or Idarubicin are frequently used with ara-c as part of initial (induction) therapy for acute myeloid leukemia. Mitoxantrone (less cardiotoxic) can be substituted for these drugs in elderly patients. Etoposide has also been added as a third agent in more refractory or relapsed cases. Vincristine, prednisone, l-asparaginase are used more in acute lymphoid leukemias. Read more...
ALL therapy also ... Includes cyclophosphamide, antimetabolite therapies such as 6-tg, 6-mp and methotrexate, and the corticosteroid dexamethasone. Methotrexate and Cytarabine are also administered via an intrathecal route for CNS prophylaxis. There are also many new agents being evaluated in clinical trials. Everyday we are learning more and applying what we learn. Read more...

Best first-line treatment for mantle cell lymphoma now: high doses of ara-c+rituximab and autologous sc transplant, or rituximab+bendamustine?

There is no. Definitive answer to your question. Studies have compared the strategies you mention. The high dose ara-c arm was closed because it was difficult to mobilize stem cells for transplant after these regimens. Bendamustine-r is a good program, and many centers would consolidate a good response with an autograft. Read more...